Position in MRK
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$1,479,163
-$424,907 QoQ
Shares Held
11,511
-27.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
#1,805
of 3,769 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Abacus Wealth Partners, LLC holds $15,909,181 across 13 Drug Manufacturers - General names. MRK ranks #4 (9.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
17,810 | $4,523,205 | |
| 2 | ABBV |
AbbVie Inc.
|
8,029 | $2,020,417 | |
| 3 | LLY |
ELI LILLY & Co
|
1,508 | $1,808,740 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
11,511 | $1,479,163 | |
| 5 | NVS |
Novartis AG
|
8,613 | $1,349,829 | |
| 6 | BIIB |
Biogen Inc.
|
4,808 | $1,038,816 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
6,107 | $771,558 | |
| 8 | NVO |
Novo Nordisk A S
|
15,818 | $758,314 |
All Filings in MRK
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,479,163 | 11,511 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $1,904,070 | 15,829 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $1,582,794 | 15,037 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $765,777 | 9,124 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $718,851 | 9,081 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $828,036 | 9,225 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,007,036 | 10,123 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $1,200,556 | 10,572 | Shares | Sole | 2024-10-03 | |
| 2024-06-30 | $1,414,291 | 11,424 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $1,470,582 | 11,145 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $1,077,335 | 9,882 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $943,330 | 9,163 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $846,616 | 7,337 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $813,777 | 7,649 | Shares | Sole | 2023-05-19 | |
| 2022-12-31 | $809,713 | 7,298 | Shares | Sole | 2023-06-01 | |
| 2022-09-30 | $628,503 | 7,298 | Shares | Sole | 2023-05-31 | |
| 2022-06-30 | $665,358 | 7,298 | Shares | Sole | 2023-05-31 | |
| 2022-03-31 | $620,462 | 7,562 | Shares | Sole | 2023-05-31 | |
| 2021-12-31 | $585,223 | 7,636 | Shares | Sole | 2023-05-31 | |
| 2021-09-30 | $606,963 | 8,081 | Shares | Sole | 2023-05-31 | |
| 2021-06-30 | $629,781 | 8,098 | Shares | Sole | 2023-05-31 | |
| 2021-03-31 | $671,145 | 8,706 | Shares | Sole | 2023-05-31 | |
| 2020-12-31 | $568,591 | 6,951 | Shares | Sole | 2023-05-31 | |
| No filing history on record for this holder in this stock. | ||||||